A new vaccine policy has been announced, allowing boosters for high-risk patients while leaving healthy adults and children in a gray area. Experts warn this could lead to fewer vaccinations and rising COVID-19 cases.
In a major shift, the FDA has approved updated Covid boosters while restricting access for children under 5, raising concerns among parents and health experts. Learn about the new guidelines and their implications.
As U.S. stocks ended the week with mixed results, the Michigan Consumer Sentiment Index revealed a drop in economic confidence. UnitedHealth saw a surge after Berkshire Hathaway increased its stake, while Sunrun soared on strong earnings. Get the full market recap!
Discover how researchers at IBM and Moderna have leveraged quantum computing to predict the complex protein structure of mRNA, marking a significant advancement in vaccine technology.
The FDA has updated warnings about potential cardiac risks associated with Pfizer and Moderna COVID-19 vaccines, especially for young men. Learn what the new labels say and what it means for vaccine safety.
The S&P 500 saw major movements with Palantir and Moderna stocks rising sharply, while Lululemon faced a significant decline in share value. Analysts weigh in on Tesla and Broadcom's performance amid market shifts.
In a groundbreaking move, the FDA has approved Moderna's lower-dose Covid-19 vaccine for older adults and at-risk individuals. Get ready for a new option this fall as Moderna targets the LP.8.1 variant!
Robert F. Kennedy Jr. canceled a critical $766 million contract with Moderna for a bird flu vaccine, raising concerns about public health and vaccine safety amidst a potential outbreak.
The U.S. government has canceled a crucial $770 million contract with Moderna for an avian flu vaccine, risking public health as pandemics prove to be a costly threat. Experts warn of the implications of prioritizing military spending over health security.
The U.S. has approved Moderna's new COVID-19 vaccine, mNexspike, specifically for high-risk groups. This innovative option offers a lower dose while maintaining effectiveness, marking a pivotal step in the fight against coronavirus.
